Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Affymetrix, Inc.    AFFX   US00826T1088

AFFYMETRIX, INC. (AFFX)

20
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
02/24/2015 02/25/2015 02/26/2015 02/27/2015 03/02/2015 Date
11.57(c) 11.64(c) 11.73(c) 11.7(c) 11.78(c) Last
506 237 1 185 754 819 522 723 782 643 763 Volume
-0.86% +0.61% +0.77% -0.26% +0.68% Change
More quotes
Company
Affymetrix, Inc. provides life science and molecular diagnostic products that enable parallel analysis of biological systems at the gene, protein and cell level.It develops, manufactures and sells products and services for genetic analysis to the genomic research centers, academic institutions,... 
Sector
Biotechnology & Medical Research
Calendar
03/03 | 08:40amPresentation
More about the company
Surperformance© ratings of Affymetrix, Inc.
Trading Rating : Investor Rating :
More Ratings
Chart AFFYMETRIX, INC.
Duration : Period :
Affymetrix, Inc. Technical Analysis Chart | AFFX | US00826T1088 | 4-Traders
Full-screen chart
Financials ($)
Sales 2015 362 M
EBIT 2015 30,7 M
Net income 2015 6,45 M
Finance 2015 49,1 M
Yield 2015 -
Sales 2016 378 M
EBIT 2016 35,2 M
Net income 2016 16,2 M
Finance 2016 85,3 M
Yield 2016 -
PER 2015 117,00
PER 2016 72,00
EV / Sales 2015 2,28x
EV / Sales 2016 2,09x
Capitalization 874 M
More Financials
Latest news on AFFYMETRIX, INC.
09:33a AFFYMETRIX : Presolicitation Notice - Notice of Intent to Sole Source- Affymetri..
02/23 AFFYMETRIX : Change in Directors or Principal Officers (form 8-K)
02/18 AFFYMETRIX : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RES..
02/09 AFFYMETRIX : Releases Fourth Quarter and Fiscal Year 2014 Results
02/06 AFFYMETRIX : to Webcast Presentation at the 2015 Leerink Global Healthcare Confe..
02/04 AFFYMETRIX : beats 4Q profit forecasts
02/04 AFFYMETRIX : Results of Operations and Financial Condition, Financial Statements..
02/04 AFFYMETRIX : Reports Fourth Quarter and Fiscal Year 2014 Results
More news
Sector news Bio Diagnostics & Testing
06:18p PUMA BIOTECHNOLOGY : Biotech reports 4Q loss
04:17p PUMA BIOTECHNOLOGY : Reports Fourth Quarter and Full Year 2014 Financial Results
08:22a ACTELION : Selexipag (Uptravi) data in pulmonary arterial hypertension to be pre..
Plus d'actualités du secteur Bio Diagnostics & Testing


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF